LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
5.04
+0.14 (2.86%)
At close: Dec 20, 2024, 4:00 PM
5.18
+0.14 (2.78%)
After-hours: Dec 20, 2024, 6:33 PM EST
LifeMD Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for LifeMD stock have an average target of 12.13, with a low estimate of 7.00 and a high estimate of 15. The average target predicts an increase of 140.67% from the current stock price of 5.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LifeMD stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +138.10% | Dec 10, 2024 |
| Mizuho | Mizuho | Hold Initiates $7 | Hold | Initiates | $7 | +38.89% | Dec 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +138.10% | Nov 11, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +197.62% | Sep 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +197.62% | Aug 20, 2024 |
Financial Forecast
Revenue This Year
209.76M
from 152.55M
Increased by 37.51%
Revenue Next Year
261.92M
from 209.76M
Increased by 24.87%
EPS This Year
-0.56
from -0.70
EPS Next Year
-0.04
from -0.56
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 217.9M | 288.8M | 344.8M | |
| Avg | 209.8M | 261.9M | 305.2M | |
| Low | 200.4M | 244.1M | 273.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 42.8% | 37.7% | 31.7% | |
| Avg | 37.5% | 24.9% | 16.5% | |
| Low | 31.4% | 16.4% | 4.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.53 | 0.24 | 0.34 | |
| Avg | -0.56 | -0.04 | 0.20 | |
| Low | -0.58 | -0.20 | 0.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.